During the past decade, Guangzhou Red cross hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Guangzhou Red cross hospital" #1 sponsor was "TaiGen Biotechnology Co., Ltd." with 3 trials, followed by "Guangzhou Red Cross Hospital" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Brigham and Women's Hospital" with 1 trials sponsored and "Ever Neuro Pharma GmbH" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Guangzhou Red cross hospital" #1 collaborator was "Guangzhou Red Cross Hospital" with 2 trials as a collaborator, "169 Military Hospital of China" with 1 trials as a collaborator, "Affiliated Hospital of Nantong University" with 1 trials as a collaborator, "Affiliated Hospital of North Sichuan Medical College" with 1 trials as a collaborator and "Ankang Hospital of Traditional Chinese Medicine" with 1 trials as a collaborator. Other collaborators include 79 different institutions and companies that were collaborators in the rest 89 trials.

According to Clinical.Site data, the most researched conditions in "Guangzhou Red cross hospital" are "Acute Respiratory Failure" (1 trials), "Burn Injuries" (1 trials), "Burn Surgery" (1 trials), "Community-acquired Pneumonia" (1 trials) and "Diabetic Kidney Disease" (1 trials). Many other conditions were trialed in "Guangzhou Red cross hospital" in a lesser frequency.

Most popular intervention types in "Guangzhou Red cross hospital" are "Drug" (9 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (2 trials), "0.9% Saline Solution" (1 trials), "Cerebrolysin" (1 trials), "Dengzhan Shengmai capsule" (1 trials) and "Dobutamine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guangzhou Red cross hospital" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Guangzhou Red cross hospital". 1 are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Guangzhou Red cross hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Guangzhou Red cross hospital, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 3 trials that are defined as “Not Applicable".